The social organization of science during the COVID-19 pandemic

Int J Risk Saf Med. 2022;33(3):223-228. doi: 10.3233/JRS-227017.

Abstract

Background: The COVID-19 pandemic has shocked society worldwide. Multiple efforts went immediately into developing treatments for managing and vaccines for preventing the disease. National and international initiatives emerged to deal with the deep economic and social inequalities in our world today.

Objective: To show that the global inequalities that have become salient during the COVID-19 pandemic and specially with the global vaccination campaign, are the result of a highly privatized system of research and development (R&D), which is first and foremost profit-driven, and where epistemic and social concerns are not prioritized.

Methods: Philosophical analysis.

Results: After exploring the current organization of scientific research, as well as its impact in the development of research at a global scale, the paper shows the way in which this highly privatized organization of research has permeated scientific research on COVID-19, identifying who is currently benefiting from pandemic science, and who on the contrary is suffering the consequences of this organization. Using the COVAX mechanism as an example, the paper argues that international efforts to counteract the power of commercially-driven science has not rendered the expected results.

Conclusions: The current organization of science ought to be shaken and restructured if we aim to be better prepared to address the global challenges of the future with the relevant scientific and technological development.

Keywords: COVAX; Social organization of science; coronavirus; pandemic science; privatization of science.

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • Organizations
  • Pandemics / prevention & control
  • SARS-CoV-2